Cognitive Impairment in Hepatitis C Patients on Antiviral Therapy

Overview

Journal Gastroenterol Hepatol (N Y)

Specialty Gastroenterology

Date 2012 Jul 17

PMID 22798739

Citations 2

Authors

Jessica Irwin

Norah Terrault

Affiliations

Soon will be listed here.

Citing Articles

Cognitive Impairments in Viral Hepatitis Patients: Causes, Manifestations, and Impact on Quality of Life.

Polukchi T Rambam Maimonides Med J. 2025; 16(1).

PMID: 39879545 PMC: 11779499. DOI: 10.5041/RMMJ.10539.

Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder.

Petkovic B, Kesic S, Pesic V Curr Pharm Des. 2020; 26(4):466-484.

PMID: 31939725 PMC: 8383468. DOI: 10.2174/1381612826666200115094642.

Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.

Lin L, Hsu T, Huang K, Tam K World J Gastroenterol. 2016; 22(23):5445-53.

PMID: 27340362 PMC: 4910666. DOI: 10.3748/wjg.v22.i23.5445.

References

Rohatiner A, PRIOR P, Burton A, Smith A, Balkwill F, Lister T . Central nervous system toxicity of interferon. Br J Cancer. 1983; 47(3):419-22. PMC: 2011317. DOI: 10.1038/bjc.1983.63. View

Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M . Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 2002; 76(19):10064-8. PMC: 136534. DOI: 10.1128/jvi.76.19.10064-10068.2002. View

Ducoulombier D, Roque-Afonso A, Di Liberto G, Penin F, Kara R, Richard Y . Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology. 2004; 39(3):817-25. DOI: 10.1002/hep.20087. View

Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C . Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol. 2001; 76(2):600-8. PMC: 136845. DOI: 10.1128/jvi.76.2.600-608.2002. View

Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P . Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol. 2002; 37(3):349-54. DOI: 10.1016/s0168-8278(02)00172-1. View

Suter C, Westmoreland B, Sharbrough F, Hermann Jr R . Electroencephalographic abnormalities in interferon encephalopathy: a preliminary report. Mayo Clin Proc. 1984; 59(12):847-50. DOI: 10.1016/s0025-6196(12)65620-1. View

Pavol M, Meyers C, Rexer J, Valentine A, Mattis P, Talpaz M . Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology. 1995; 45(5):947-50. DOI: 10.1212/wnl.45.5.947. View

Manns M, McHutchison J, Gordon S, Rustgi V, Shiffman M, Reindollar R . Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001; 358(9286):958-65. DOI: 10.1016/s0140-6736(01)06102-5. View

Asnis G, De La Garza 2nd R . Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol. 2006; 40(4):322-35. DOI: 10.1097/01.mcg.0000210099.36500.fe. View

10.

Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, Ennen J . Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol. 2004; 41(5):845-51. DOI: 10.1016/j.jhep.2004.07.022. View

11.

Bonkovsky H, Snow K, Malet P, Back-Madruga C, Fontana R, Sterling R . Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007; 46(3):420-31. PMC: 1995129. DOI: 10.1016/j.jhep.2006.10.009. View

12.

Fontana R, Bieliauskas L, Lindsay K, Back-Madruga C, Wright E, Snow K . Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology. 2007; 45(5):1154-63. DOI: 10.1002/hep.21633. View

13.

Forton D, Allsop J, Main J, Foster G, Thomas H, Taylor-Robinson S . Evidence for a cerebral effect of the hepatitis C virus. Lancet. 2001; 358(9275):38-9. DOI: 10.1016/S0140-6736(00)05270-3. View

14.

Turner E, Blackwell A . 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. Med Hypotheses. 2005; 65(1):138-44. DOI: 10.1016/j.mehy.2005.01.026. View

15.

Moulignier A, Allo S, Zittoun R, Gout O . Recombinant interferon-alpha-induced chorea and frontal subcortical dementia. Neurology. 2002; 58(2):328-30. DOI: 10.1212/wnl.58.2.328. View

16.

Fried M . Side effects of therapy of hepatitis C and their management. Hepatology. 2002; 36(5 Suppl 1):S237-44. DOI: 10.1053/jhep.2002.36810. View

17.

Kraus M, Schafer A, Wissmann S, Reimer P, Scheurlen M . Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin. Clin Pharmacol Ther. 2005; 77(1):90-100. DOI: 10.1016/j.clpt.2004.09.007. View

18.

Forton D, Thomas H, Murphy C, Allsop J, Foster G, Main J . Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002; 35(2):433-9. DOI: 10.1053/jhep.2002.30688. View

19.

. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements. 2004; 19(3):1-46. View

20.

Raison C, Borisov A, Broadwell S, Capuron L, Woolwine B, Jacobson I . Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry. 2005; 66(1):41-8. PMC: 1615913. DOI: 10.4088/jcp.v66n0106. View